Contrast-induced Nephropathy
📧 Sign up to get email alerts when something new happens for Contrast-induced Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: N-Acetyl Cystein and Contrast Nephropathy [Phase 3]
Phase 3 clinical trial evaluating N-acetylcysteine for prevention of radiographic contrast–induced nephropathy in patients with chronic kidn…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction [NA]
A clinical trial investigating prevention of contrast-induced nephropathy in patients with acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy [Phase 4]
This Phase 4 trial update examines N-GAL as a treatment for contrast-induced nephropathy in patients with coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: Comparing Effects of Patient-specific Versus Non-patient-specific Computerized Reminder System [NA]
Clinical trial update comparing patient-specific versus non-patient-specific computerized reminder systems, conducted by Taipei Medical Univ…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy
This clinical trial update reports on long-term follow-up data for using remote ischemic preconditioning to prevent contrast-induced nephrop…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization [Phase 2]
Phase 2 clinical trial evaluating the impact of ACE inhibitors on contrast-induced nephropathy in patients undergoing cardiac catheterizatio…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease [Phase 3]
Phase 3 trial evaluating sodium bicarbonate to reduce contrast-induced chronic kidney injury was terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Prevention of Contrast Induced Nephropathy (NIC) by Intravenous Versus Oral Rehydration [NA]
A completed clinical trial comparing intravenous versus oral rehydration for prevention of contrast-induced nephropathy in patients with acu…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury [NA]
A completed clinical trial evaluated intravenous high-dose N-acetylcysteine plus sodium bicarbonate for the prevention of contrast-induced a…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy [Phase 4]
This clinical trial update reports results from a Phase 4 study comparing sodium bicarbonate to normal saline for preventing contrast-induce…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Hydration and Contrast-Induced Nephropathy in Primary Angioplasty [Phase 4]
A Phase 4 trial update assessing hydration to prevent contrast-induced nephropathy in patients undergoing primary angioplasty has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Patients With Renal Impairment Undergoing CT [Phase 4]
Phase 4 clinical trial update examining outcomes for patients with renal impairment undergoing CT with contrast, focusing on contrast-induce…
-
CLINICAL_TRIALS trial_result · 2011-11-09Clinical Trial Update: Evaluation of Intravenous N-acetylcysteine to Prevent Contrast Media Induced Nephrotoxicity in an Emergency Center
A completed clinical trial evaluated intravenous N-acetylcysteine for the prevention of contrast-induced nephrotoxicity in emergency departm…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Polymorphism of Oxidative Stress Genes in the Pathogenesis and Antioxidant Prevention of Contrast Induced Nephropathy [NA]
A completed clinical trial from Huashan Hospital evaluating whether genetic polymorphisms in oxidative stress pathways influence contrast-in…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Prevention of Contrast-Induced Nephropathy [NA]
This entry notes the completed clinical trial evaluating prevention of contrast-induced nephropathy sponsored by the University of Alberta.
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: Bicarbonate v Saline to Prevent Contrast Nephropathy [Phase 4]
Phase 4 trial comparing bicarbonate versus saline to prevent contrast-induced nephropathy was terminated.
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) [Phase 4]
A Phase 4 clinical trial comparing iso-osmolar iodixanol with low-osmolar iohexol contrast agents in acute myocardial infarction patients un…
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: Sodium Bicarbonate in Preventing Contrast Induced Nephropathy [NA]
Clinical trial update on using sodium bicarbonate to prevent contrast-induced nephropathy; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection [Phase 4]
A Phase 4 trial assessed whether a sodium bicarbonate bolus can prevent contrast-induced nephropathy in patients undergoing emergent coronar…
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine [NA]
Clinical trial comparing sodium bicarbonate to sodium chloride and N-acetylcysteine for preventing contrast-induced nephropathy has complete…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients [Phase 3]
Phase 3 clinical trial evaluating whether alpha tocopherol can prevent contrast-induced nephropathy in patients with chronic kidney disease;…
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy
This completed clinical trial evaluates neutrophil gelatinase-associated lipocalin (NGAL) as a blood marker to assess the risk of contrast-i…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention [Phase 3]
Phase 3 clinical trial comparing induced diuresis with matched hydration versus standard hydration for prevention of contrast-induced nephro…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy [Phase 4]
Phase 4 trial evaluating intravenous Acetadote (N-acetylcysteine) for prevention of contrast-induced nephropathy. The update does not provid…
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography [Phase 4]
Phase 4 clinical trial update evaluating prevention of contrast-induced nephropathy in diabetic patients undergoing coronary angiography.